Parameter | Definition | Value | Reference |

L | Lattice size | 250 | Ad hoc |

H_PR | Production rate of normal healthy CD | 18 cells/iteration | [17] |

CTL_PR | Production rate of CTLs | 30 cells/iteration (in primary infection phase) & 3 cell every 14 iterations (after the end of primary infection phase) | [17] [18] |

AB_PR | Production rate of Anti Bodies | 50 cells/iteration (in primary infection phase) & 5 cell every 14 iterations (after the end of primary infection phase) | [17] [18] |

H_LSL | Life span limit of normal Healthy CD | 4 iterations | [17] |

CTL_LSL | Life span limit of CTLs | 15 iterations | [17] [18] |

AB_LSL | Life span limit of Anti Bodies | 15 iterations | [18] |

V_LSL | Life span limit of HIV | 3 iterations | [17] |

R | Number of infected A | 4 cells | [12] |

T | Delay time needed to re-activate the A | 30 iterations | [14] |

P | The probability of converting a healthy cell into an A1 cell in the presence of infecting factors | 0.99 | [14] |

P | The probability of replacing a dead cell by a normal healthy cell | 0.99 | [12] |

P | The probability of replacing each new healthy cell by an A | 10 | [12] |

P | The probability of identifying an infected A | 55%, 75% and 95% respectively 3, 4 and 5 weeks after infection | Ad hoc |

P | The probability of identifying an HIV | 0.95% | Ad hoc |

P | The probability of releasing an HIV | 0.99 | [19] |

P | The probability of reactivating an A | 0.0005 | [14] |

P | The effectiveness of PI and RTI antiretroviral drugs | Varies between 0 to 0.9 | [15] |